Evidence map›Paper›PMID 40407404›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

Perceptions, Attitudes, and Concerns on Artificial Intelligence Applications in Patients with Cancer.

Enes Erul, Yusuf Aktekin, Furkan Berk Danışman, Şükrü Armanç Gümüştaş, Büşra Saraç Aktekin, Emre Yekedüz, Yüksel Ürün

Registry-linked trialAbstract read
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07600541 (Perceptions of Kidney Transplant Recipients Regarding the Role of Artificial Intelligence in Medicine), which is not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07600541 recruitingnot on this map

Perceptions of Kidney Transplant Recipients Regarding the Role of Artificial Intelligence in Medicine

TypeobservationalSponsorParis Translational Research Center for Organ TransplantationRan2026 to 2026Enrolled1,000ConditionsKidney Transplant
3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Article
  3. The use of generative AI tools among individuals with cancer and their caregivers: a cross-sectional study of awareness, attitudes, and experiences.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Public perceptions of AI-assisted cancer care in Abu Dhabi, UAE: A cross-sectional survey.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Artificial Intelligence and the future of clinical trials.Contemporary clinical trials communications · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Enes ErulDivision of Medical Oncology, Department of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Türkiye.ORCID 0000-0002-2487-2087
Yusuf AktekinDepartment of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Türkiye.
Furkan Berk DanışmanBanking and Payments Department, Bank of Canada, Ottawa, ON, Canada.ORCID 0009-0005-6563-2193
Şükrü Armanç GümüştaşDepartment of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Türkiye.
Büşra Saraç AktekinDepartment of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Türkiye.
Emre YekedüzDivision of Medical Oncology, Department of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Türkiye.
Yüksel ÜrünDivision of Medical Oncology, Department of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IntroductionThe use of artificial intelligence (AI) in oncology has increased rapidly, transforming various healthcare areas such as pathology, radiology, diagnostics, prognosis, genomics, treatment planning, and clinical trials. However, perspectives, comfort levels, and concerns about AI in cancer care remain largely unexplored.Materials and MethodsThis prospective, descriptive cross-sectional survey study was conducted between May 20, 2024 and October 22, 2024, among 363 patients with cancer from two different hospitals affiliated with Ankara University, a tertiary care center in Türkiye. The survey included three distinct sections: (1) Perceptions: Patients' general views on AI's impact in oncology; (2) Attitudes: Comfort level with AI performing medical tasks; (3) Concerns: Specific fears related to AI implementation (eg, diagnostic errors, data privacy, healthcare costs). Survey responses were summarized descriptively, and differences by age, gender, and education were analyzed using chi-square tests.ResultsA majority (50.7%) believed AI would somewhat (32%) or significantly (18.7%) improve healthcare. However, one-third of patients (33.1%) were very uncomfortable with AI diagnosing cancer, with higher discomfort among less-educated participants (

Indexed as

Artificial IntelligenceNeoplasmsAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedProspective StudiesSurveys and Questionnairesartificial intelligencecancer carechatbotscomfort levelshealthcare concernsmachine learning and deep learning systemsnatural language processingpatient perspectives

Identifiers

PMID40407404
PMCPMC12102565

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.